Kit Kit - Masu kera, masana'anta, masu ba da kaya daga China - Alishir
Koyaushe muna tunani da yin aiki da dacewa da canjin yanayi, da girma. Muna nufin a nasarar cimma burinta da jiki da kuma rayuwa ga Kanamycin - Kit8167,Hcp residual kit, Ka'idodin DNA, RNA RAIDAY, E na gwaji na Cori Cori. Don ƙarin tambayoyi ko kuma ya kamata ku iya samun wata tambaya game da kayanmu, ku tabbata cewa kada ku yi shakka ku kira mu. Nace a kan tsarin gudanar da mahimmancin mahimmancin mutane da ƙwararrun masanan gargajiya, yanzu mun tsara ƙudurinmu don bayar da masu siyar da adadin da kuma bayan sabis ɗin da ake samu da kuma bayan sabis ɗin da ake samu da kuma bayan sabis ɗin da muke samu. Kulawa da dangantakar abokantaka da masu sayenmu, mun kirkiro maganin maganin mu na yau da kullun don gamsar da sabbin buƙatun da kuma binsu na yau da kullun. A shirye muke mu fuskance damuwar da kuma inganta don fahimtar duk damar a cikin ciniki na ƙasa.E.coli DNA Kit, E.coli RNA RENEAT, E.coli hcp residual kit, E.coli DNA.
A cikin Maris 18 - 19, 2023, babban taron masana'antu na Amurka 8 na shekara 8 ya faru ne a cibiyar Expso Expso Expso. A yayin taron, "2022 an sanar da masu samar da kayayyakin" an sanar da masu lashe gasar, tare da Bipharma reopharma da "2022 EB
Fitar da DNA tsarin halitta ne a cikin ilimin kwayoyin halitta, yana wasa muhimmiyar rawa a cikin nau'ikan bincike da aikace-aikace na likita. Ci gaban kayan masarufi na dNA ya sauya wannan tsari, yana yin shi acces
Wajibi ga filayen E.coli Resindin DNA Gwajin DNA kamar sel da garken gene, filayen vialy suna da wadatarwa da fermented ta amfani da E. Cori a matsayin mai watsa shiri. Da kuma plasmid plasmid yana buƙatar yin amfani da ingancin ingancin EC.Coli Ruwan Cinikin DNA kafin a iya amfani da shi
A Afrilu 19, 2023, Jiiangsu Hillssu Hillase Bipharma Co., Ltd. (WANINAFTER ANA GAME DA HANKALIN HANKALI) ya sanar da nadin Dokta Dr. Yuan Zhao a matsayin Babban Jami'in Fasahar ta. Dr. Yuan Zhao zai dauki alhakin sabbin bincike da ci gaba da kuma ESTA
Gabatarwa zuwa gano HCP ta fannin ci gaba da sauri na biopharmautical m, tabbatar da tsarkakakku da amincin kayayyakin warkewa. Daya daga cikin mahimmin fannoni na wannan tsari shine ganowar mai masa kwararru (HCPs), w
A ranar 30 ga Disamba, 2022, "na" 2022 China Biopharmaleuthal Repernancin Insiyawar Insiyawa "a hukumance ta a ranar bude sarkar" na biyu ta kasar Sin da canjin canji. " Jianguwa Hillsene Bio
Wannan kamfanin yana da ra'ayin "inganci mafi kyau, farashin sarrafawa, farashin aiki sun fi dacewa", saboda haka suna da dalilin da muke buƙata don yin aiki tare.
Kamfanin yana da albarkatun arziki, infrin injuna, masu samar da ma'aikata masu kyau, da fatan kun ci gaba da inganta da kuma kammala samfuran ku, fatan ku da kyau!